A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII

被引：0
|
作者：
Maran, A [1 ]
Crazzolara, D [1 ]
Nicoletti, M [1 ]
Costa, S [1 ]
dal Pos, M [1 ]
Tiengo, A [1 ]
Avogaro, A [1 ]
Bruttomesso, D [1 ]
机构：
[1] Cattedra Malattie Metab, Padua, Italy
来源：
DIABETOLOGIA | 2005年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
902
引用
收藏
页码：A328 / A328
页数：1
相关论文
共 50 条
  • [31] MORPHOLOGICAL FINDINGS IN PLACENTAE OF INSULIN-DEPENDENT DIABETIC-PATIENTS TREATED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
    LAURINI, RN
    VISSER, GHA
    VANBALLEGOOIE, E
    SCHOOTS, CJF
    PLACENTA, 1987, 8 (02) : 153 - 165
  • [32] Comparison of multiple daily injections (MDI) vs continuous subcutaneous insulin infusion (CSII) methods of insulin delivery in children with Type 1 diabetes in a small district general hospital
    Moult, D.
    Chandrasekaran, S.
    DIABETIC MEDICINE, 2013, 30 : 100 - 101
  • [33] Continuous subcutaneous insulin infusion (CSII) vs glargine insulin in Type 1 diabetic children:: a comparative pilot study.
    Schiaffini, R
    Ciampalini, P
    Giannone, G
    Spera, S
    Rivalta, V
    Pavone, N
    Bottazzo, GF
    Crinò, A
    DIABETOLOGIA, 2003, 46 : A245 - A245
  • [34] Continuous subcutaneous insulin infusion (CSII) and multiple daily insulin (MDI) regimen display similar patterns of blood glucose (BG) excursions in pediatric type 1 diabetes (DM)
    Alemzadeh, R
    Palma-Sisto, P
    Parton, E
    Holzum, M
    DIABETES, 2004, 53 : A100 - A100
  • [35] Continuous Subcutaneous Insulin Infusion (CSII) versus Multiple Daily Injections (MDI): Impact on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes
    Shi, Xiling
    Cai, Qinghua
    Xin, Siming
    Wu, Shan
    Shen, Yousu
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (11):
  • [36] Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)
    Bruttomesso, D.
    Bonomo, M.
    Costa, S.
    Dal Pos, M.
    Di Cianni, G.
    Pellicano, F.
    Vitacolonna, E.
    Dodesini, A. R.
    Tonutti, L.
    Lapolla, A.
    Di Benedetto, A.
    Torlone, E.
    DIABETES & METABOLISM, 2011, 37 (05) : 426 - 431
  • [37] Good metabolic control with a continuous subcutaneous insulin infusion (CSII) in type 2 diabetic patients uncontrolled by insulin optimisation
    Donnet, J. -P.
    Courreges, J-P.
    Clavel, S.
    Gabreau, T.
    Gouet, D.
    Verlet, E.
    Cosson, E.
    Jan, P.
    Cirette, B.
    Leutenegger, E.
    DIABETOLOGIA, 2010, 53
  • [38] Continuous Subcutaneous Insulin Infusion (CSII) and fear of hypoglycaemia in patients with type 1 diabetes: five years of study
    Carreira, M.
    Ruiz de Adana, M. S.
    Orozco, A.
    Linares, F.
    Fontalba, M.
    Guerrero, M.
    Anarte, M. T.
    DIABETOLOGIA, 2015, 58 : S462 - S462
  • [39] Treatment of type 1 diabetes with continuous subcutaneous insulin infusion (CSII) in adults in Iceland
    Boovarsdottir, Katrin Olof
    Aspelund, Thor
    Guomundsdottir, Arna
    LAEKNABLADID, 2011, 97 (05): : 291 - 295
  • [40] DIET FOR INSULIN-DEPENDENT DIABETIC-PATIENTS ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) TREATMENT
    CHANTELAU, E
    SONNENBERG, GE
    BEST, F
    BERGER, M
    DIABETES CARE, 1984, 7 (03) : 301 - 301
12345